China Medical System - CHSYF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.93
+0 (0.00%)

This chart shows the closing price for CHSYF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New China Medical System Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CHSYF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CHSYF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for China Medical System in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.93.

This chart shows the closing price for CHSYF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in China Medical System. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/26/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/5/2023The Goldman Sachs GroupUpgradeNeutral ➝ Buy
(Data available from 6/24/2019 forward)

News Sentiment Rating

-0.55 (Sell)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 5 very negative mentions
11/27/2023
  • 1 very positive mentions
  • 7 positive mentions
  • 4 negative mentions
  • 3 very negative mentions
12/27/2023
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
1/26/2024
  • 4 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 8 very negative mentions
2/25/2024
  • 1 very positive mentions
  • 7 positive mentions
  • 5 negative mentions
  • 4 very negative mentions
3/26/2024
  • 2 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
4/25/2024
  • 1 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
5/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/24/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
China Medical System logo
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. It also offers DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company provides Elcatonin injection for osteoporosis; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. In addition, it is involved in the agriculture and livestock activities. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
Read More

Today's Range

Now: $0.93
Low: $0.93
High: $0.93

50 Day Range

MA: $0.93
Low: $0.93
High: $0.93

52 Week Range

Now: $0.93
Low: $0.93
High: $0.93

Volume

N/A

Average Volume

733 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of China Medical System?

The following Wall Street analysts have issued research reports on China Medical System in the last twelve months: The Goldman Sachs Group, Inc..
View the latest analyst ratings for CHSYF.

What is the current price target for China Medical System?

0 Wall Street analysts have set twelve-month price targets for China Medical System in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for China Medical System in the next year.
View the latest price targets for CHSYF.

What is the current consensus analyst rating for China Medical System?

China Medical System currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CHSYF will outperform the market and that investors should add to their positions of China Medical System.
View the latest ratings for CHSYF.

What other companies compete with China Medical System?

How do I contact China Medical System's investor relations team?

China Medical System's physical mailing address is 6/F-8/F, Block B, Shenzhen, Guangdong 518052. The company's listed phone number is 852-2369-7678. The official website for China Medical System is www.cms.net.cn. Learn More about contacing China Medical System investor relations.